Victory Capital Management
HRMY icon

Victory Capital Management’s Harmony Biosciences HRMY Stock Holding History

Victory Capital Management’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5M Buy
399,037
+47,407
+13% +$1.5M 0.01% 1004
2026
Q1 		$9.85M Buy
351,630
+79,058
+29% +$2.59M 0.01% 1086
2025
Q4 		$10.2M Buy
272,572
+36,904
+16% +$1.21M 0.01% 1055
2025
Q3 		$6.5M Buy
235,668
+60,881
+35% +$2.1M ﹤0.01% 1242
2025
Q2 		$5.52M Sell
174,787
-37,107
-18% -$1.19M ﹤0.01% 1283
2025
Q1 		$7.03M Buy
211,894
+65,285
+45% +$2.34M 0.01% 1179
2024
Q4 		$5.04M Buy
146,609
+77,611
+112% +$2.67M 0.01% 1262
2024
Q3 		$2.76M Sell
68,998
-15,966
-19% -$561K ﹤0.01% 1400
2024
Q2 		$2.56M Buy
84,964
+29,816
+54% +$897K ﹤0.01% 1369
2024
Q1 		$1.85M Buy
55,148
+37,368
+210% +$1.2M ﹤0.01% 1476
2023
Q4 		$574K Sell
17,780
-14,809
-45% -$413K ﹤0.01% 1959
2023
Q3 		$1.07M Buy
32,589
+3,605
+12% +$125K ﹤0.01% 1622
2023
Q2 		$1.02M Sell
28,984
-14,579
-33% -$503K ﹤0.01% 1664
2023
Q1 		$1.42M Buy
43,563
+3,317
+8% +$151K ﹤0.01% 1521
2022
Q4 		$2.22M Buy
40,246
+18,592
+86% +$1.02M ﹤0.01% 1398
2022
Q3 		$959K Sell
21,654
-139
-0.6% -$6.78K ﹤0.01% 1755
2022
Q2 		$1.06M Sell
21,793
-3,302
-13% -$149K ﹤0.01% 1711
2022
Q1 		$1.13M Buy
25,095
+14,877
+146% +$607K ﹤0.01% 1741
2021
Q4 		$436K Buy
+10,218
New +$407K ﹤0.01% 2220

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's HRMY Position: Q2 2026 in Review

Victory Capital Management increased its Harmony Biosciences (HRMY) stake by 13% in Q2 2026, buying an estimated $1.5M and bringing the position to 399,037 shares worth $14.5M. The position accounts for 0.01% of the portfolio, ranked #1004.

Victory Capital Management first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Victory Capital Management held 399,037 shares of Harmony Biosciences worth $14.5M as of Q2 2026.
  • Victory Capital Management bought 47,407 Harmony Biosciences shares in Q2 2026, an estimated $1.5M.
  • Harmony Biosciences made up 0.01% of Victory Capital Management's portfolio in Q2 2026, its #1004 holding.
  • Victory Capital Management first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.